688513.SH
Chengdu Easton Biopharmaceuticals Co., Ltd.
SSE · Healthcare · Biotechnology · CN
CNY 41.84
+2.55%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- 25.98x
- P/E 2027E
- 23.81x
- P/E 2028E
- 21.45x
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- 26.00x
- PEG TTM
- —
- Price / book
- 2.47x
- Price / sales
- 5.36x
- Price / cash flow
- 23.26x
Enterprise value
- Enterprise value
- CNY 7.1B
- EV / sales
- 5.25x
- EV / EBITDA
- 17.36x
- EV / EBIT
- 23.69x
- Market cap
- CNY 7.4B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Mar 1, 2026